Congress and the Florida Legislature must eliminate cost disparities between opioid and non-opioid options.
To read more letters to the editor, go to oregonlive.com/opinion.
Since 1999, the American opioid epidemic has killed more than half a million people, and the staggering majority have been ...
Opinion
1don MSNOpinion
We increasingly hear pleas from those who are suffering agonizing pain not only about pain management but also about ways to end their lives.
Treatment for chronic pain still relies heavily on opioids. While effective, they are highly addictive and potentially deadly ...
1don MSNOpinion
Don’t fall for the distraction of tariffs. To reduce fentanyl deaths, we need to get opioid users into treatment and reduce ...
U.S. researchers said Wednesday they have reproduced the pain-relieving effects of cannabis with a synthesized compound that ...
According to a new study by WashU Medicine researchers, male and female rats with a chronic pain condition release different ...
9d
Clinical Trials Arena on MSNLexicon’s non-opioid therapy for DPNP beats placebo in pain reductionThe company has chosen to move ahead to Phase III trials with its 10mg dose after it saw a 1.74-point reduction in pain score ...
The Boston-based company's new medication, called Journavx, is being placed on a tier that means it might be costlier than ...
During my time serving in the state legislature, I heard from numerous constituents impacted by the opioid crisis ...
MIRA Pharmaceuticals, Inc. (NASDAQ:MIRA), a clinical-stage pharmaceutical company focused on developing therapies for neurological and neuropsychiatric disorders, today announced the successful ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results